Development of individualized therapeutic vaccines for early-stage solid tumor patients using viral vector technology.
A
CSR Analysis score
The organization is among the top 5% of organizations with the most committed CSR positioning, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: June 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Cellectis
B
Development of allogeneic CAR-T cell therapies using gene-edited T-cells to treat cancer, leveraging TALEN® technology for off-the-shelf immunotherapies.
Priothera
B
Development of innovative therapies for hematological malignancies, focusing on immune modulators to enhance outcomes in allogeneic hematopoietic cell transplantation and CAR T cell therapy.
Xenothera
B
Development of innovative immunological treatments using glyco-humanized antibodies. Conducts clinical trials and collaborates with partners in areas like oncology and xenotransplantation.
Initiatives identified among leaders
Bilan carbone global
“Priothera développe des thérapies innovantes pour ...” - PriotheraInformation complète et consentement éthique des patients
“Xenothera informe exhaustivement les patients part...” - XenotheraCode de conduite
“Priothera développe des thérapies innovantes pour ...” - Priothera40% of similar organizations communicate on CSR issues
+132 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports